Use of HER2 gene amplification to identify patients with metastatic colorectal cancer resistant to anti-EGFR monoclonal antibodies.

被引：4
|
作者：
Barbara, Cecilia
Martin, Vittoria
Molinari, Francesca
Landi, Lorenza
Riva, Alice
Saletti, Piercarlo
de Dosso, Sara
Geva, Ravit
Tejpar, Sabine
Fountzilas, George
Kalogeras, Konstantine T.
Frattini, Milo
Cappuzzo, Federico
机构：
[1] Osped Civile Livorno, Dept Med Oncol, Livorno, Italy
[2] Ist Cantonale Patol, Lab Mol Diagnost, Locarno, Switzerland
[3] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[4] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[5] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[6] Univ Hosp Gasthuisberg, Leuven, Belgium
[7] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
474
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SKIN RASH AND OUTCOME IN COLORECTAL CANCER (CRC) PATIENTS TREATED WITH ANTI-EGFR MONOCLONAL ANTIBODIES
    Petrelli, F.
    Borgonovo, K. F.
    Cabiddu, M.
    Ghilardi, M.
    Cremonesi, M.
    Maspero, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 192 - 192
  • [32] HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer
    Wenbai Huang
    Yijiao Chen
    Wenju Chang
    Li Ren
    Wentao Tang
    Peng Zheng
    Qi Wu
    Tianyu Liu
    Yu Liu
    Ye Wei
    Jianmin Xu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 993 - 1002
  • [33] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Saridaki, Zacharenia
    Georgoulias, Vassilis
    Souglakos, John
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1177 - 1187
  • [34] Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies
    Lievre, Astrid
    Laurent-Puig, Pierre
    PERSONALIZED MEDICINE, 2009, 6 (02) : 145 - 157
  • [35] Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies
    Zhang, Wu
    Gordon, Michael
    Lenz, Heinz-Josef
    ANNALS OF MEDICINE, 2006, 38 (08) : 545 - 551
  • [36] Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis
    Rossini, Daniele
    Germani, Marco Maria
    Pagani, Filippo
    Pellino, Antonio
    Dell'Aquila, Emanuela
    Bensi, Maria
    Liscia, Nicole
    Moretto, Roberto
    Boccaccino, Alessandra
    Prisciandaro, Michele
    Manglaviti, Sara
    Schirripa, Marta
    Vivolo, Raffaella
    Scartozzi, Mario
    Santini, Daniele
    Salvatore, Lisa
    Pietrantonio, Filippo
    Loupakis, Fotios
    Falcone, Alfredo
    Cremolini, Chiara
    CLINICAL COLORECTAL CANCER, 2020, 19 (03) : 191 - +
  • [37] Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer
    Cripps, C.
    Gill, S.
    Ahmed, S.
    Colwell, B.
    Dowden, S.
    Kennecke, H.
    Maroun, J.
    Samson, B.
    Thirlwell, M.
    Wong, R.
    CURRENT ONCOLOGY, 2010, 17 (06) : 272 - 278
  • [38] Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).
    D'Silva, Ashley James
    Dotan, Efrat
    Kloth, Dwight D.
    Beck, Andrew
    Cohen, Steven J.
    Denlinger, Crystal Shereen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [39] Rechallenge with anti-EGFR antibodies in metastatic colorectal cancer: A single center analysis
    Duarte Mendes, A.
    Vicente, R.
    Caleca, T.
    Silva, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S149 - S149
  • [40] Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer: a case report and review of the literature
    Moroni, Mauro
    Veronese, Silvio
    Sartore-Bianchi, Andrea
    Artale, Salvatore
    Siena, Salvatore
    TARGETED ONCOLOGY, 2008, 3 (02) : 127 - 130
12345